课题基金 / 基金详情

BILE ACID INDUCED AP1 SIGNALING IN COLON CANCER

BILE ACID INDUCED AP1 SIGNALING IN COLON CANCER
胆汁酸在结肠癌中诱导 AP1 信号传导
批准号:
6563869
负责人:
JESSE D. MARTINEZ
金额:
$13.05万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2002
资助国家:
美国
项目状态:
已结题
起止时间:
2002-01-01 至 2002-12-31

项目摘要

项目成果

JESSE D. MARTINEZ的其他基金

相似基金

相关文献

中文摘要
翻译
申请人描述:该项目的总体目标是
英文摘要
APPLICANT'S DESCRIPTION: The overall objective of this project is to delineate the mechanism through which bile acids alter colon tumor etiology by examining the effect that bile acid-mediated changes in signal transduction and gene expression have on cell fate. Deoxycholic acid (DCA) can stimulate gene expression by activating the AP-1 transcription factor through up regulation of the ras/erk pathway, suggesting that DCA acts as a tumor promoter by aberrantly up regulating protooncogene activity and mimicking the effects of gene mutations. Interestingly, DCA also stimulates a separate protein kinase C-dependent pathway that may also cause up regulation of AP-1 through GSK-3 in the Wnt-1 signaling pathway. Interestingly, ursodeoxycholic acid (UDCA), a bile acid with chemopreventative properties, does not stimulate AP-1 activity. Instead, UDCA stimulated signaling cooperates with activated AP-1 and/or PKC signaling to induce apoptosis. Importantly, we have determined that AP-1 may be up-regulated in Min(+) mouse tumors and in the flat mucosa of AOM treated mice long after final exposure to this carcinogen, suggesting that AP-1 is aberrantly activated in vivo under conditions that foster tumor development. Consequently, we hypothesize that bile acids modulate colon cancer etiology by altering signal transduction that leads to activation of AP-1. Furthermore, we speculate that UDCA may function as a chemopreventive agent by selectively inducing apoptosis in cells where AP-1 and/or PKC is aberrantly stimulated. We will test this by: 1) determining whether DCA can modify the activity of and/or dysregulate Wnt-1 signaling, 2) examine the effect of germline mutations in the APC gene on tumor promotion/chemopreven-tion by bile, 3) characterize UDCA-mediated signaling activity in colon-derived cell lines, 4) determine whether UDCA can induce apoptosis in colonic epithelial cells with aberrant AP-1 activity, 5) Examine the effect that a diet supplemented with UDCA has on signal transduction and gene expression in the colonic epithelium of human subjects.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
(PQA 2) Obesity & Obstructive Sleep Apnea in Hepatocellular Carcinoma Progression
  • 批准号:
    8686225
  • 项目类别:
  • 资助金额:
    $23.07万
  • 财政年份:
    2014
  • 负责人:
    JESSE D. MARTINEZ
  • 依托单位:
(PQA 2) Obesity & Obstructive Sleep Apnea in Hepatocellular Carcinoma Progression
  • 批准号:
    8856183
  • 项目类别:
  • 资助金额:
    $13.18万
  • 财政年份:
    2014
  • 负责人:
    JESSE D. MARTINEZ
  • 依托单位:
Mechanisms of colon cancer chemoprevention by ursodeoxycholic acid
  • 批准号:
    8204971
  • 项目类别:
  • 资助金额:
    $24.13万
  • 财政年份:
    2010
  • 负责人:
    JESSE D. MARTINEZ
  • 依托单位:
Mechanisms of colon cancer chemoprevention by ursodeoxycholic acid
  • 批准号:
    8601360
  • 项目类别:
  • 资助金额:
    $6.9万
  • 财政年份:
    2010
  • 负责人:
    JESSE D. MARTINEZ
  • 依托单位:
国内基金
海外基金
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
  • 批准号:
    LBY21H010001
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2020
  • 负责人:
    郑绪阳
  • 依托单位:
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
  • 批准号:
    81703335
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    20.0万元
  • 批准年份:
    2017
  • 负责人:
    卫高菲
  • 依托单位:
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
  • 批准号:
    81670594
  • 项目类别:
    面上项目
  • 资助金额:
    58.0万元
  • 批准年份:
    2016
  • 负责人:
    陈昊
  • 依托单位:
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
  • 批准号:
    81470791
  • 项目类别:
    面上项目
  • 资助金额:
    73.0万元
  • 批准年份:
    2014
  • 负责人:
    董家鸿
  • 依托单位: